Navigation Links
FDA Panel Gives Blessing to New Weight-Loss Drug
Date:5/12/2012

THURSDAY, May 10 (HealthDay News) -- An advisory panel to the U.S. Food and Drug Administration on Thursday recommended approval of the weight-loss medication lorcaserin, even though concerns remain about cardiovascular side effects.

If the agency were to give the nod to the drug, lorcaserin would become the first new weight-loss pill made available to Americans in a decade. The FDA is not bound to follow the advice of its expert panels, but it typically does.

The panel of experts voted 18 to 4, with one abstention, for approval, saying the drug's benefits "outweigh the potential risks when used long term" for people battling excess weight, the Associated Press reported.

Lorcaserin has not always received such a favorable reception. According to the AP, in 2010 scientists voiced concern that the drug might come with health risks, citing tumors that had developed in animal testing involving the drug.

However, Arena Pharmaceuticals, the San Francisco-based company that makes lorcaserin, has since submitted additional data in hopes the FDA might look more favorably on the drug.

According to a review of the available research posted by FDA staff online on Tuesday, that new data suggests that lorcaserin carries only a "negligible risk" of cancer in humans, the AP said. But concerns over the potential for cardiovascular risks -- hypertension in people with diabetes, for example, or injury to heart valves -- remain.

According to the AP, lorcaserin is one of three experimental weight-loss drugs that the FDA is taking a second look at after first saying no to the medications in 2010 or early 2011 because of concerns about significant side effects.

In February, another new weight-loss drug, Qnexa, was endorsed by an FDA advisory panel. The agency is expected to make a final decision on Qnexa in July.

More information

Find out more about healthy weight loss
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. U.S. Panel Rejects Ovarian Cancer Screening
2. Panel of serum biomarkers may reduce number of lung biopsies needed
3. FDA Panel Cites Clot Risk From Contraceptive Patch
4. Panel endorses active monitoring and delay of treatment for low-risk prostate cancer
5. Expert Panel Pinpoints Environmental Culprits in Breast Cancer
6. FDA Panels to Weigh Safety of Newer Forms of the Pill
7. Panel of melanoma mutations opens door to new treatment possibilities
8. Many on Medical Guideline Panels Have Conflicts of Interest: Study
9. Panels Rejection of PSA Test Spurs Mixed Reaction From Experts
10. Osteoporosis Drugs Safety Subject of FDA Panel
11. U.S. Panel Recommends Free Coverage of Birth Control
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Panel Gives Blessing to New Weight-Loss Drug 
(Date:5/27/2015)... silver spring, MD (PRWEB) May 27, 2015 ... Company in USA, helped its client to launch an ... Payment app allows merchants to accept credit, debit and ... be downloaded from Google Play at: https://play.google.com/store/apps/details?id=com.simpalm.paymentgateway . ... Jan 2013 and has been recently updated by SIMpalm. ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 Kudolife ... its much-anticipated Apple Watch release available at ... health-conscious users to track their calories and activities with ... background to identify activity type for accurate tracking. , ... with the sought-after Apple Watch, which will allow users ...
(Date:5/27/2015)... HomeTown Health, along with other physician health ... on May 13 & 14. In each city, a ... with the group of representatives and receive assistance, answers ... attended. , Referred to as the "Rural Physician ... Health Information Technology and ICD-10 resources with primarily Physicians ...
(Date:5/26/2015)... Local dentist Abid Paghdiwala is now helping Philadelphia ... of Pearl Dental Arts recently became an American Academy ... leading national organization for dentists who treat snoring and ... alternative treatment to the standard continuous positive airway pressure ... CPAP machine, which includes a face mask, tubing and ...
(Date:5/26/2015)... May 27, 2015 Securityhunter ... (MATOC) by the United States Department of Health and ... The MATOC was awarded through the General ... (FSS) for the PSC, which is a fee-for-service agency. ... one year options, and is an enterprise–wide physical security ...
Breaking Medicine News(10 mins):Health News:Forte Payment System Launches Android Version of Payment App 2Health News:Kudolife Launches into Apple Watch App Market with Newest Release 2Health News:Kudolife Launches into Apple Watch App Market with Newest Release 3Health News:HomeTown Health Leads Rural Physician Bus Tour; Brings Resources and Education to North Georgia 2Health News:HomeTown Health Leads Rural Physician Bus Tour; Brings Resources and Education to North Georgia 3Health News:Philadelphia sleep apnea dentist now offers oral appliances to treat snoring 2Health News:Securityhunter Has Been Awarded a Multiple Award Task Order Contract (MATOC) by the Department of Health and Human Services 2
... in the Journal Psychological bulletin that having positive emotions ... better health and long life.// This research study was ... emotions had a direct impact on health as they ... protects from psychological stress. The researchers feel that interpreting ...
... protein was found to be responsible for transferring ... very important for reducing oxidative stress as Cysteine ... radical scavenging activity in brain.// Free radicals are ... antioxidants. Professor Raymond Swanson and his team from ...
... Gladstone Institute of Neurological Disease have found that the ... disease //that acts by inactivating the conversion of glucose ... fragments released from apoE. ,The apoE protein ... by not providing the glucose present in the brain ...
... at the University of Toronto stimulates the muscles of ... walking function in those with no hope of walking.// ... functional electrical stimulation (FES), a process that sends controlled ... can help patients enhance their walking skills by improving ...
... Institute (SERI) found that increasing the contrast of details ... the visually impaired. // ,The U.S. study provides ... help millions suffering eye diseases. People who may benefit ... degeneration, diabetic retinopathy and other causes of low vision. ...
... and community medicine and colleagues developed the latest tool for ... a tool which is called the Newest vital sign. It ... on an ice cream nutrition label. Based on the number ... can be calculated. , Then it is for ...
Cached Medicine News:Health News:Visually impaired prefer specially enhanced TV 2Health News:Visually impaired prefer specially enhanced TV 3
(Date:5/27/2015)... , May 27, 2015  BioDelivery Sciences International, Inc. (NASDAQ: ... and Chief Executive Officer of BDSI, will present at two important ... Conference Tuesday, June 2 8:30 AM Eastern Time Grand Hyatt, ... William Blair 35 th Annual Growth Stock Conference Tuesday, ... Seasons Hotel, Chicago, IL , ...
(Date:5/27/2015)... Biomedical Catalyst Award to ... Cancer  Crescendo Biologics Limited (Crescendo) today ... (ADC) programme with the support of a Biomedical ... UK. This feasibility award will enable the validation ... novel product format based on Crescendo,s Humabody™ antibody ...
(Date:5/26/2015)... 2015  AbbVie (NYSE: ABBV ) presented ... of its investigational, all-oral, interferon (IFN)- and ribavirin ... the Annual Meeting of the Japan Society of ... 1 GIFT-I evaluated genotype 1b (GT1b) chronic ... and without cirrhosis, who were either treatment-naïve or ...
Breaking Medicine Technology:BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference and the William Blair Growth Stock Conference 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference and the William Blair Growth Stock Conference 3Crescendo Biologics Expands ADC Programmes with Innovate UK Funding Award 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 3AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 4AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 5AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 6
... Stryker Corporation (NYSE: SYK ) today announced that the U.S. ... undertaken to address issues raised in two Warning Letters received in 2007 ... , , ... certain quality system requirements at its reconstructive implant manufacturing facility in ...
... China , May 19 /PRNewswire-Asia-FirstCall/ -- ... the "Company"),(OTC Bulletin Board: CRUI), a manufacturer and distributor ... pharmaceuticals, construction materials,PVC products, foods and beverages and cosmetics, ... March 31, 2010 . , , ...
Cached Medicine Technology:Stryker Announces Resolution of Two FDA Warning Letters 2China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 2China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 3China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 4China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 5China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 6China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 7China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 8China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 9China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 10China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 11China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 12
Titanium. Straight shafts with 6 mm platform and Pierse tips. Flat serrated handle with dull finish....
0.12 mm, 1 x 2 teeth set at 45 degrees with 5 mm tying platform. Serrated handle with polished finish....
Serrated handle with 7 mm tying platform and polished finish. Teeth: 0.25 mm, 2 x 2 set at 45 degrees....
5 mm tying platform, serrated cross action handle with polished finish. Teeth: 0.10 mm, 1 x 2 set at 45 degrees....
Medicine Products: